Startseite » People » Professors » Ries » Publikationen

Publikationen

  Originalarbeiten  
1. Egea V, Zahler S, Rieth N, Neth P, Popp T, Kehe K, Jochum M, Ries C. Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/ß-catenin signaling. Proc Natl Acad Sci U S A 109(6):E309-16, 2012. Impact 9.7
2 Grismayer B, Sato S, Kopitz C, Ries C, Soelch S, Schmitt M, Baretton G, Krüger A, Luther T, Kotzsch M, Magdolen V. Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes. Biological Chemistry 393(12):1449-1455, 2012. Impact 3.0
3. Egea V, Schichor C, Popp T, Neth P, Karow M, Goldbrunner R, Berninger B, Jochum M, Ries C. TNF-α regulation of ERK1/2 respecifies human mesenchymal stem cells to a neural fate and promotes CXCR4/SDF-1α mediated migration. Cell Death and Differentiation 18:853-863, 2011. Impact 9.0
4. Popp T, Egea V, Kehe K, Steinritz D, Schmidt A, Jochum M, Ries C. Sulfur mustard induces differentiation in human primary keratinocytes: opposite roles of p38 and ERK1/2 MAPK. Toxicology Letters 204:43-51, 2011. Impact 3.6
5. Nakahata AM, Mayer B, Ries C, de Paula CA, Karow M, Neth P, Sampaio MU, Jochum M, Oliva ML. The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines. Biological Chemistry, 392: 327-336, 2011. Impact 3.6
6. Karow M, Popp T, Egea V, Ries C, Jochum M, Neth P. Wnt signaling in mouse mesenchymal stem cells: impact on proliferation, invasion, and MMP expression. Journal of Cellular and Molecular Medicine, 13:2606-2520, 2009. Impact 4.6
7. Ries C, Popp T, Egea V, Kehe K, Jochum M. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: upregulation in response to sulphur mustard. Toxicology, 263:26-31, 2009. Impact 3.6
8. Böcker W, Docheva D, Prall C, Egea V, Pappou E, Roßmann O, Popov C, Mutschler W, Ries C, Schieker M. IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells. Journal of Molecular Medicine, 86:1183–1192, 2008. Impact 5.2
9. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood, 109:4055-4063, 2007. Impact 10.9
10 Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H, Jochum M. Identification of a novel 82-kDa variant of proMMP-9 associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Biochemical Journal, 405:547-558, 2007. Impact 4.1
11. Neth P, Ries C, Karow M, Egea V, Ilmer M, Jochum M. The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Reviews, 3:18-29, 2007. Impact 6.8
12. Heidinger M, Kolb H, Krell HW, Jochum M, Ries C. Modulation of autocrine TNF-α-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biological Chemistry, 387:69-78, 2006 Impact 2.7
13. Popp O, Heidinger M, Ruiz-Heinrich L, Ries C, Jochum M, Gil-Parrado S. The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells. Biological Chemistry, 384:951-958, 2003. Impact 3.4
14. Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JGM, Jochum M. The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Research, 63:337-341, 2003. Impact 8.6
15. Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JGM, Jochum M. Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease. British Journal of Cancer, 88:1084-1090, 2003. Impact 3.9
16. Lüttichau I von, Djafarzadeh R, Herger A, Cohen C, Mojaat A, Jochum M, Ries C, Nelson PJ, Kretzler M. Identification of a signal transduction pathway that regulates MMP-9 mRNA expression in glomerular injury. Biological Chemistry, 383:1271-1275, 2002. Impact 2.5
17. Zang C, Liu H, Ries C, Ismair MG, Petrides PE. Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment. Journal of Cancer Research and Clinical Investigation, 126:33-40, 2000. Impact 2.1
18. Ries C, Loher F, Ismair MG, Zang C, Petrides PE. Matrix metallo-proteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clinical Cancer Research, 5:1115-1124, 1999.  Impact 3.4
19. Ismair MG, Ries C, Lottspeich F, Zang C, Kolb H, Petrides PE. Autocrine regulation of MMP-9 gene expression and secretion by TNF-α in NB4 leukemic cells: involvement of TNF receptor I. Leukemia, 12:1136-1143, 1998. Impact 3.5
20. Ries C, Lottspeich F, Dittmann KH, Petrides PE. HL-60 leukemia cells release an autocatalytically truncated form of MMP-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases. Leukemia, 10:1520-1526, 1996. Impact 2.9
21. Dittmann KH, Lottspeich F, Ries C, Petrides PE. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of metalloproteinases (TIMPs). Experimental Hematology, 23:155-160, 1995. Impact 3.2
  Übersichtsartikel  
1. Neth P, Ries C, Karow M, Egea V, Ilmer M, Jochum M. The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. Stem Cell Reviews, 3:18-29, 2007. Impact 6.8
2.. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biological Chemistry Hoppe-Seyler, 376:345-355, 1995.  Impact 2.5
  Buchbeiträge  
  Ries C, Egea V. Human mesenchymal stem cell transdifferentiation to neural cells: role of tumor necrosis factor alpha. Hayat MA (ed.). Stem Cells and Cancer Stem Cells, Vol. 8, 71-78, 2012.  

 

 

 

 
 
IPEKlogo

Direktor:

Prof. Dr. med. Christian Weber

 

Institute for Cardiovascular Prevention (IPEK)

 

Pettenkoferstraße 8a & 9

80336 München

 

Tel.: 089-4400-54351

Fax: 089-4400-54352

Mail: ipek.office@med.lmu.de